Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2011
  • Online publication date: August 2011

14 - Unusual causes of tremor

References

1. Deutschl G, Bain PG, Brin M and Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on tremor. Mov Disord 1998; 13: 2–23.
2. Manyam B. Uncommon forms of tremor. In: Watts RL, Koller WC, eds. Movement Disorders, Neurologic Principles and Practice. 2nd ed. New York: McGraw-Hill; 2004.
3. Bain PG. Tremor. Parkinsonism Relat Disord 2007; 13(Suppl 3): S369–74.
4. Bain PG. The effectiveness of treatments for essential tremor. Neurologist 1997; 305–21.
5. Fishman PS. Paradoxical aspects of parkinsonian tremor. Mov Disord 2008; 168–73.
6. De Jong H. Action tremor in Parkinson’s disease. J Nerv Ment Dis 1926; 64: 1.
7. Deutschl G, Volkmann J, Raethjen J. Differential diagnosis, pathophysiology and therapy. In: Jankovic J, Tolosa E, eds. Parkinson’s Disease and Movement Disorders. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
8. Baysal L, Acarer A, Celebisoy N. Post-ischemic Holmes’ tremor of the lower extremities. J Neurol 2009; 256(12): 2079–81.
9. Ferlazzo E, Morgante F, Rizzo V et al. Successful treatment of Holmes tremor by levetiracetam. Mov Disord 2008: 23(14): 2101–3.
10. Nikkhah G, Propkop T, Hellwig B, Lucking CH, Ostertag CB. Deep brain stimulation of the nucleus ventralis intermedius for Holmes (rubral) tremor and associated dystonia caused by upper brainstem lesions: report of two cases. J Neurosurg 2004; 100: 1079–83.
11. Elble RJ. Tremor: clinical features, pathophysiology, and treatment. Neurol Clin 2009; 27(3): 679–95.
12. Bacsi AM, Fung VS, Colebatch JG. Sway patterns in orthostatic tremor: impairment of postural control mechanisms. Mov Disord 2005; 20(11): 1469–75.
13. FitzGerald PM, Jankovic J. Orthostatic tremor: An association with essential tremor. Mov Disord 1991; 6: 60.
14. Wills AJ, Thompson PD, Findley LJ, Brooks DJ. A positron emission tomography study of primary orthostatic tremor. Neurology 1996; 46(3): 747–52.
15. Rodriguez JP, Edwards DJ, Walters SE et al. Gabapentin can improve stability and quality of life in primary orthostatic tremor. Mov Disord 2005; 20: 865–70.
16. Willis AJ, Brusa L, Wang HC, Brown P, Marsden CD. Levodopa may improve orthostatic tremor: case report and trial of treatment. J Neurosurg Psychiatry 1999; 66(5): 681–4.
17. Krauss JK, Weigel R, Blahak C et al. Chronic spinal cord stimulation in medically intractable orthostatic tremor. J Neurol Neurosurg Psychiatry 2006; 77(9): 1013–16.
18. Gerschlager W, Münchau A, Katzenschlager R et al. Natural history and syndromic associations of orthostatic tremor: a review of 41 patients. Mov Disord 2004; 19(7): 788–95.
19. Pearce JMS. Palatal myoclonus (syn. palatal tremor). Eur Neurol 2008; 60: 312–15.
20. Fabiani G, Teive HA, D et al. Palatal myoclonus: report of two cases. Arq Neuropsiquiatr 2000; 58(3B): 901–4.
21. Penney SE, Bruce IA, Saeed SR. Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature. J Neurol 2006; 253(7): 857–60.
22. Růzicka E, Jech R, Zárubová K, Roth J, Urgosík D. VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy. Mov Disord 2003; 18(10): 1192–5.
23. Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol 2005; 4(12): 866–76.
24. Stacy M, Jankovic J. Tardive tremor. Mov Disord 1992; 7: 53–7.
25. Aschner M, Erikson KM, Hernández EH, Tjalkens R. Manganese and its role in Parkinson’s disease: from transport to neuropathology. Neuromol Med 2009; 11(4): 252–66.
26. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS Pesticides and Parkinson’s disease – is there a link? Environ Health Perspect 2006; 114(2): 156–64.
27. Koller W, O’Hara R, Durus W, Bauer J. Tremor in chronic alcoholism. Neurology 1985; 35: 1660.
28. Ellingsen DG, Bast-Pettersen R, Efskind J et al. Hand tremor related to smoking habits and the consumption of caffeine in male industrial workers. Neurotoxicology 2006; 27(4): 525–33.
29. Louis ED. Kinetic tremor: differences between smokers and non-smokers. Neurotoxicology 2007; 28(3): 569–75.
30. Zdonczyk D, Royse V, Koller WC: Nicotine and tremor. Clin Neuropharmacol 1988; 11: 282.
31. Abila B, Wilson JF, Marshall RW, Richens A. The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment. Br J Clin Pharmacol 1985; 20(4): 369–76.
32. McKeon A, Ahlskog JE, Bower JH et al. Psychogenic tremor: long term prognosis in patients with electrophysiologically-confirmed disease. Mov Disord 2009; 24: 72–6.
33. Masuhr F, Wissel J, Müller J, Scholz U, Poewe W. Quantification of sensory trick impact on tremor amplitude and frequency in 60 patients with head tremor. Mov Disord 2000; 15(5): 960–4.
34. Marsden CE, Harrison MJG. Idiopathic torsion dystonia (dystonia musculorum, deformans): a review of forty-two patients. Brain 1974; 97: 793.
35. Jankovic J, Leder S, Warner D, Schwatz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991; 41: 1088.
36. Kim JW, Lee PH. Dystonic head tremor associated with a parietal lesion. Eur J Neurol 2007; 14: e32–3.
37. Rothwell JC, Traub MM, Marsden CD. Primary writing tremor. J Neurol Neurosurg Psychiatry 1979; 42: 1106.
38. Bain PG, Findley LJ, Britton TC, Rothwell JC et al. Primary writing tremor. Brain 1995; 118: 1461–72.
39. Wills AJ, Jenkins IH, Thompson PD et al. A positron emission study of cerebral activation associated with essential and writing tremor. Arch Neurol 1995; 52: 299.
40. McDaniel KD, Cummings JL, Shain S. The “yips”: a focal dystonia of golfers. Neurology 1989; 39: 192–5.
41. Bawden M, Maynard I. Towards an understanding of the personal experience of the “yips” in cricketers. J Sports Sci 2001; 19(12): 937–53.
42. Adler CH. Sports-related task-specific dystonia: the yips. In: Stacy M, ed. Handbook of Dystonia. New York: Informa Healthcare; 2007.
43. Stinear CM, Coxon JP, Fleming MK, Lim VK, Prapavessis H, Byblow WD. The yips in golf: multimodal evidence for two subtypes. Med Sci Sports Exerc 2006; 38(11): 1980–9.
44. Racette BA, Dowling J, Randle J et al. Thalamic stimulation for primary writing tremor. J Neurol 2001; 248: 380.
45. Pascual-Castroviejo I, Pascual Pascual SI, Viaño J, Martínez V. Posttraumatic intention tremor: report of a case with a lesion in the mesencephalic area. Neurologia 2000; 15(3): 128–31.
46. Sharma P, Eesa M, Poppe AY, Goyal M. Teaching NeuroImage: posttraumatic palatal tremor. Neurology 2008; 71(13): e30.
47. Deuschl G, Blumberg H, Lücking CH. Tremor in reflex sympathetic dystrophy. Arch Neurol 1991; 48(12): 1247–52.
48. Ellis RJ. Tremor and movement disorders after whiplash type injuries. J Neurol Neurosurg Psychiatry 1997; 87: 1884–6.
49. Ellis SJ. Tremor and other movement disorders after whiplash type injuries. J Neurol Neurosurg Psychiatry 1997; 63(1): 110–12.
50. Jankovic J. Peripherally induced movement disorders. Neurol Clin 2009; 27(3): 821–32.
51. Andrew J, Fowler CJ, Harrison MJG, Kendall BE. Post-traumatic tremor due to vascular injury and its treatment by stereotactic thalamotomy. J Neurol Neurosurg Psychiatry 1982; 45: 560.
52. Umemura A, Samadani U, Jaggi JL, Hurtig HI, Baltuch GH. Thalamic deep brain stimulation for posttraumatic action tremor. Clin Neurol Neurosurg 2004; 106(4): 280–3.
53. Jacob PC, Pratap Chand R. Posttraumatic rubral tremor responsive to clonazepam. Mov Disord 1998; 13(6): 977–8.
54. Moringlane JR, Pützer M, Barry WJ. Bilateral high-frequency electrical impulses to the thalamus reduce voice tremor: acoustic and electroglottographic analysis – a case report. Eur Arch Otorhinolaryngol 2004; 261(6): 334–6.
55. Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs 2002; 16(10): 663–8.
56. Micheli F, Grañana N, Scorticati MC, Giannaula RJ, Reboredo G. Unilateral postural and action tremor resulting from thalamic toxoplasmosis in a patient with acquired immunodeficiency syndrome. Mov Disord 1997; 12(6): 1096–8.
57. Floris-Moore MA, Amodio-Groton MI, Catalano MT. Adverse reactions to trimethoprim/sulfamethoxazole in AIDS. Ann Pharmacother 2003; 37(12): 1810–3.
58. Venkatesan A, Frucht S. Movement disorders after resuscitation from cardiac arrest. Neurol Clin 2006; 24(1): 123–32.
59. Pujol A, Pujol J, Graus F et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993; 43(1): 65–9.
60. Ferrara J, Jankovic J. Acquired hepatocerebral degeneration. J Neurol 2009; 256(3): 320–2.
61. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G,Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115: 720–6.
62. Machado A, Chien HF, Deguti MM et al. Neurological manifestations in Wilson’s disease: report of 119 cases. Mov Disord 2006; 21(12): 2192–6.
63. Frucht S, Sun D, Schiff N, Eidelberg D, Gilliam TC. Arm tremor secondary to Wilson’s disease. Mov Disord 1998; 13(2): 351–3.
64. Kung AW. Neuromuscular complications of thyrotoxicosis. Clin Endocrinol (Oxf) 2007; 67(5): 645–50.
65. Tan EK, Lo YL, Chan LL. Graves disease and isolated orthostatic tremor. Neurology 2008; 70(16 Pt 2): 1497–8.
66. Martino D, Chew NK, Mir P, Edwards MJ, Quinn NP, Bhatia KP. Atypical movement disorders in antiphospholipid syndrome. Mov Disord 2006; 21(7): 944–9.
67. Moroo I, Hirayama K, Kojima S. Involuntary movements caused by thalamic lesion. Rinsho Shinkeigaku 1994; 34(8): 805–11.
68. Dethy S, Luxen A, Bidaut LM, Goldman S. Hemibody tremor related to stroke. Stroke 199; 24(12): 2094–6.
69. Finsterer J, Muellbacher W, Mamoli B. Yes/yes head tremor without appendicular tremor after bilateral cerebellar infarction. J Neurol Sci 1996; 139(2): 242–5.
70. Keller S, Dure LS. Tremor in childhood. Semin Pediatr Neurol 2009; 16: 60–70.
71. Ferrara J, Jankovic J. Epidemiology and management of essential tremor in children. Paediatr Drugs 2009; 11(5): 293–307.
72. Jarman PR, Wood NW, Davis MT et al. Hereditary geniospasm: linkage to chromosome 9q13-q21 and evidence for genetic heterogeneity. Am J Hum Genet. 1997; 61(4): 928–33.
73. Mahant P, Stacy M, Sivakumar K. Treatment of hereditary geniospasm with botulinum toxin. 6th International Congress of Parkinson’s Disease and Movement Disorders, 2000.
74. Perez-Duenas B, Valls-Sole J, Fernandez-Alverez E et al. Characterization of tremor in pheylketonuric patients. J Neurol 2005; 252: 1328–34.
75. Garcia-Cazorla A, Rabier D, Touati G et al. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol 2006; 59: 121–7.